Here's Why We're Wary Of Buying Medtronic's (NYSE:MDT) For Its Upcoming Dividend
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and IDEAYA Biosciences (IDYA)
Medtronic Stock Declines 5.6% in a Month: Time to Buy the Dip?
Investors Five-year Losses Continue as Medtronic (NYSE:MDT) Dips a Further 3.5% This Week, Earnings Continue to Decline
Express News | Three companies abstained from the fifth batch of consumables centralized procurement.
Baird Adjusts Medtronic Price Target to $90 From $93, Maintains Neutral Rating
Least Shorted S&P 500 Stocks in November
Medtronic Analyst Ratings
DuraStat Launches Commercial Partnership With Medtronic Cranial and Spinal Technologies Business
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $89
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Mizuho Securities Maintains Medtronic(MDT.US) With Buy Rating, Announces Target Price $100
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $96
Unusual Options Activity: BRKR, TSLA and Others Attract Market Bets, BRKR V/OI Ratio Reaches 250.0
EST Dec 17th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
Saudi Arabia Telemedicine Market Report 2024, With Key Player Profiles for Aster DM Healthcare, Sesneber International, GE Healthcare, Medtronic, Cisco Saudi Arabia and Altibbi
Express News | Medtronic PLC : Mizuho Raises Target Price to $100 From $98
Medtronic Currently Down 10 Consecutive Days, on Pace for Longest Losing Streak Since February 2006 -- Data Talk
Goldman Sachs Adjusts Price Target on Medtronic to $83 From $84, Maintains Sell Rating